- Conditions
- Osteopenia, Osteoporosis
- Interventions
- alendronate sodium
- Drug
- Lead sponsor
- Glaser Pediatric Research Network
- Network
- Eligibility
- 8 Years to 22 Years
- Enrollment
- 90 participants
- Timeline
- 2002 – 2007
- U.S. locations
- 4
- States / cities
- Los Angeles, California • San Francisco, California • Stanford, California + 1 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Necrotizing Enterocolitis
- Interventions
- Not listed
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 1 Day to 2 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2003
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Obesity
- Interventions
- glucophage XR
- Drug
- Lead sponsor
- Glaser Pediatric Research Network
- Network
- Eligibility
- 13 Years to 18 Years
- Enrollment
- 76 participants
- Timeline
- 2003 – 2007
- U.S. locations
- 5
- States / cities
- Los Angeles, California • San Francisco, California • Stanford, California + 2 more
- Conditions
- Cancer
- Interventions
- Doxorubicin
- Drug
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 1 Year to 21 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2003
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Idiopathic Thrombocytopenic Purpura (ITP), Immune Thrombocytopenic Purpura (ITP)
- Interventions
- rituximab
- Drug
- Lead sponsor
- Neufeld, Ellis J, MD, PhD
- Individual
- Eligibility
- 18 Months to 18 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2005
- U.S. locations
- 9
- States / cities
- Los Angeles, California • Palo Alto, California • San Francisco, California + 6 more